H.C. Wainwright Maintains a Neutral Rating at $7.00 a Share on LM Funding America Inc. (NASDAQ: LMFA) Analyst Michael Donavon of H.C. Wainwright Maintains a Neutral rating on LM Funding America Inc. (NASDAQ: LMFA) with a price target of $7.00.In the report...
Allegion plc (NYSE: ALLE), Acquires Trimco Hardware Allegion plc (NYSE: ALLE), a leading global security products and solutions provider, through its subsidiaries, has acquired privately held Trimco Hardware (Trimco), including its brands and other assets.Trimco is a...
TransUnion (NYSE: TRU) Completes Acquisition of Credit Prequalification and Distribution Platform Monevo TransUnion (NYSE: TRU) today announced the completion of the acquisition of Monevo from Quint Group Limited. The news follows January’s announcement that...
Kazia Therapeutics (NASDAQ: KZIA) Sells IP and Trademarks Rights for Cantrixil for $1M Kazia Therapeutics Limited (KZIA) (“Kazia” or “the Company”), an oncology-focused drug development company, today announced the sale of all intellectual...
LM Funding America (NASDAQ: LMFA) Announces Fourth Quarter and Full Year 2024 Earnings Call for March 31, 2025 LMFA focuses exclusively on mining Bitcoin, the largest and most widely adopted cryptocurrency, using energy-intensive equipment optimized for proof-of-work...
Soleno Therapeutics (NASDAQ: SLNO) Announces U.S. FDA Approval of VYKAT(TM) XR, the stock is up pre-market Soleno Therapeutics, Inc. (NASDAQ: SLNO) announced that the U.S. Food and Drug Administration (FDA) has approved VYKAT XR (diazoxide choline) extended-release...
